What is the comparison between disposable plain catheters and disposable hydrogel coated catheters for Clean Intermittent Catheterization (CIC) in Spinal Cord Injury (SCI) patients?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 26, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Comparison of Disposable Plain vs Hydrogel-Coated Catheters for CIC in SCI Patients

Based on the best available evidence, hydrogel-coated (gel reservoir) catheters show minimal clinical advantage over plain catheters for reducing symptomatic UTIs in SCI patients, while costing substantially more, making plain non-coated catheters the most cost-effective choice for clean intermittent catheterization. 1

Key Clinical Outcomes

Urinary Tract Infection Rates

  • A systematic review including 8 RCTs found that the type of intermittent catheter used has little effect on the rate of symptomatic infection 1
  • The annual probability of symptomatic UTI was 67.7% (95% CI: 60.9-74.2%) across all catheter types, indicating minimal difference between coated and uncoated catheters 1
  • One study comparing gel reservoir catheters to sterile non-coated catheters in 18 SCI patients found fewer UTIs with gel reservoir catheters (4 vs 12 patients, p=0.03), but this was a small crossover trial with limited follow-up 2

Urethral Trauma and Microhematuria

  • Gel-lubricated catheters demonstrated significantly reduced urethral cell counts compared to standard PVC catheters (6.7 ± 2.8 x 10⁴ vs 15.1 ± 8.9 x 10⁴, p=0.01), indicating less urethral trauma 3, 2
  • Microhematuria was significantly less common with hydrophilic-coated and gel-lubricated catheters compared to PVC catheters (p<0.05) 3
  • Long-term follow-up (median 7 years) with hydrophilic catheters showed no increase in severe urethral complications such as strictures or false passages 4

Patient Satisfaction and Comfort

  • Patient satisfaction scores were significantly better with gel-lubricated catheters compared to standard PVC catheters (mean VAS: 2.33 ± 1.06 vs 4.72 ± 2.13, p=0.022) 2
  • Hydrophilic and gel-lubricated catheters enable easier and more comfortable catheterization compared to standard PVC catheters 3

Cost-Effectiveness Analysis

Economic Impact

  • Clean non-coated catheters are the most cost-effective option with a total cost of £11,879 and 11.928 QALYs, representing the baseline for comparison 1
  • Hydrophilic catheters cost £38,875 with 12.003 QALYs, representing an incremental cost of £26,997 for only 0.076 additional QALYs 1
  • Gel reservoir catheters cost £40,248 with 12.450 QALYs, showing the highest quality of life but at substantial additional cost (£28,369 incremental cost for 0.522 QALYs) 1
  • The probability of hydrophilic catheters being cost-effective was 0%, while clean non-coated catheters had an 89.2% probability of being cost-effective 1

Individual Catheter Costs

  • Hydrophilic catheters cost £1.28 each (range: £0.97-£1.66) 1
  • Gel reservoir catheters cost £1.36 each (range: £0.98-£1.43) 1
  • Non-coated catheters cost £1.19 each (range: £0.39-£1.47) 1

Clinical Decision Algorithm

When to Use Plain Non-Coated Catheters

  • First-line choice for all SCI patients initiating CIC due to superior cost-effectiveness with comparable infection rates 1
  • Patients without history of urethral complications or strictures 4
  • Settings where cost considerations are important and infection rates are acceptable 1

When to Consider Gel-Coated Catheters

  • Patients with documented recurrent urethral trauma or bleeding with standard catheters 3, 2
  • History of urethral strictures or difficult catheterization in the acute phase after indwelling catheter removal 4
  • Patients reporting significant discomfort or pain with standard catheters affecting compliance 3, 2
  • When patient satisfaction and quality of life are prioritized over cost considerations 1

Important Caveats and Pitfalls

Evidence Limitations

  • The current evidence base is limited, and the systematic review authors note that additional data about infection incidence, urethral complications, patient compliance, and quality of life are needed before widespread practice changes 1
  • Most studies had relatively short follow-up periods (weeks to 1 year), with only one study examining long-term outcomes up to 9 years 4
  • Sample sizes were generally small, with individual studies ranging from 18 to 123 patients 1

Clinical Considerations

  • Asymptomatic bacteriuria is inevitable with long-term catheterization and should not be treated unless clinical symptoms exist 5
  • The risk of multidrug-resistant UTI (7.0%, 95% CI: 5.1-9.2%) and UTI-associated bacteremia (3.6%, 95% CI: 3.4-3.8%) exists regardless of catheter type 1
  • Proper catheterization technique and frequency (typically 4-6 times daily) are more important than catheter type for preventing complications 6
  • Male patients, elderly patients, longer duration of SCI, and greater severity of injury are associated with increased risk of symptomatic UTI regardless of catheter type 5

Practical Implementation

  • When transitioning from indwelling catheters to CIC, early urethral trauma may occur; using hydrophilic or gel-coated catheters during this transition period may prevent progression to strictures 4
  • Intermittent catheterization is strongly recommended over indwelling catheters for bladder emptying in neurogenic lower urinary tract dysfunction 6
  • Catheter selection should account for patient dexterity, cognitive ability, and living situation, as these factors affect compliance more than catheter type 1

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.